Sixty percent of children with ADHD in a recent study demonstrated persistence of symptoms into their mid-20's, and 41 percent had both symptoms and impairment as young adults.

Poor early morning psychostimulant symptoms management for children and adolescents with attention deficit/hyperactivity disorder (ADHD) can involve functional impairment for the patients and emotional impacts for parents and caregivers, according to findings from a pair of online questionnaire studies presented at the U.S. Psychiatric & Mental Health Congress.

When Alyson Gerdes of the Marquette University Department of Psychology met Al Castro, program director of the health research department at the United Community Center (UCC), they found that they were unknowingly working toward the same goal...Now, Gerdes and Castro run Familia Sanas (“Healthy Families”), which focuses on "disseminating a culturally-appropriate ADHD treatment to Spanish-speaking, Latino families in the Greater Milwaukee area," according to Castro.

Babies born to severely overweight mothers have a greater chance of developing conditions such as ADHD, research has found. Public health strategies that help women planning pregnancies to reach and maintain a healthy weight could help address the risk, researchers say.

For patients with comorbid bipolar disorder and attention-deficit/hyperactivity disorder (ADHD), the psychostimulant methylphenidate (multiple brands) can be used safely without increasing the risk for manic episodes if combined with a mood stabilizer, a large observational study suggests.

An estimated 1 in 10 children in the United States have been diagnosed with ADHD, according to Dr. Matthew Lorber, a psychiatrist at Lenox Hill Hospital...He says Adderall, one brand of stimulant, can help with the impulsiveness, high energy, or short attention span ADHD patients may face. After a recent New York Times article discussing Adderall's dangerously addictive nature, Lorber wants to set the record straight about these pills.

When considering medication for children and adolescents with ADHD, depression and anxiety, PCPs should start with a low dose of a long-acting drug, and then gradually increase as needed, according to data presented at the 2016 AAP National Conference & Exhibition.